Dr. Benjamin M. Ellingson
Claim this profileUCLA / Jonsson Comprehensive Cancer Center
Studies Brain Tumor
Studies Cerebral Gliomas
3 reported clinical trials
6 drugs studied
Area of expertise
1Brain Tumor
IDH positive
IDH negative
2Cerebral Gliomas
IDH positive
IDH negative
Affiliated Hospitals
Clinical Trials Benjamin M. Ellingson is currently running
MRI
for Glioblastoma
This clinical trial uses a type of imaging scan called magnetic resonance imaging (MRI) to study brain tumor biology in patients with glioblastoma that can be removed by surgery (resectable). Malignant gliomas are the second leading cause of cancer mortality in people under the age of 35 in the United States. Glioblastoma is a type of malignant glioma with very poor patient prognosis. There are currently only about 3 drugs approved by the Food and Drug Administration (FDA) for the treatment of glioblastoma, one of them being administration of bevacizumab, which is very expensive. It is the most widely used treatment for glioblastoma with dramatic results. However, previous clinical trials have not demonstrated an overall survival benefit across all patient populations with glioblastoma that has returned after treatment (recurrent). The study aims to identify which patients who will benefit from bevacizumab therapy by observing MRI images and corresponding imaging biomarkers.
Recruiting1 award N/A2 criteria
Metabolic MRI
for Brain Tumor
This clinical trial constructs and tests a novel multinuclear metabolic magnetic resonance imaging (MRI) sequence in patients with glioma (brain tumor) that is newly diagnosed or has come back (recurrent). This trial aims to develop new diagnostic imaging technology that may bridge gaps between early detection and diagnosis, prognosis, and treatment in brain cancer.
Recruiting1 award Phase < 13 criteria
More about Benjamin M. Ellingson
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Benjamin M. Ellingson has experience with
- Simultaneous Multinuclear Metabolic MRI
- Biospecimen Collection
- Magnetic Resonance Imaging
- Arterial Spin Labeling Magnetic Resonance Imaging
- Oxygen-weighted SAGE-EPI
- PH-Weighted Amine CEST
Breakdown of trials Benjamin M. Ellingson has run
Brain Tumor
Cerebral Gliomas
Malignant Glioma
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin M. Ellingson specialize in?
Benjamin M. Ellingson focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are IDH negative.
Is Benjamin M. Ellingson currently recruiting for clinical trials?
Yes, Benjamin M. Ellingson is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Benjamin M. Ellingson has studied deeply?
Yes, Benjamin M. Ellingson has studied treatments such as Simultaneous Multinuclear Metabolic MRI, Biospecimen Collection, Magnetic Resonance Imaging.
What is the best way to schedule an appointment with Benjamin M. Ellingson?
Apply for one of the trials that Benjamin M. Ellingson is conducting.
What is the office address of Benjamin M. Ellingson?
The office of Benjamin M. Ellingson is located at: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA / Jonsson Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.